Sponsors (6)
The resolution increases public-health attention, awareness, and justification for enforcement against deadly counterfeit fentanyl pills—potentially reducing youth overdoses—but may shift resources toward policing, further stigmatize people who use drugs, and raise compliance costs for online commerce.
Youth and teens (roughly ages 14–23) may see increased public awareness and prevention efforts about counterfeit fentanyl pills, which could reduce overdoses and deaths in this age group.
Local governments, parents, and communities could gain a stronger federal public-health focus that brings more funding or programs for surveillance, pill testing, and harm-reduction resources to detect and respond to counterfeit pills.
Law-enforcement agencies may be able to justify increased enforcement and interdiction actions based on highlighted large seizures and lethal-dose data, potentially reducing supply from trafficking networks.
Low-income individuals and local governments may see resources shift toward policing and interdiction rather than treatment and long-term prevention, limiting access to addiction services.
People who use drugs (including young adults and people with disabilities) may face increased stigma and public fear if lethal-dose statistics are publicized without clear harm-reduction guidance, which could discourage seeking help.
Small online sellers and tech platforms could face new compliance burdens if policy responses emphasize stricter online commerce restrictions, raising costs for small-business owners and tech workers.
Based on analysis of 2 sections of legislative text.
Expresses congressional findings and concern about the rise of counterfeit pills containing lethal doses of illicit fentanyl and rising youth overdoses.
Official title: Supporting the mission and goals of National Fentanyl Awareness Day in 2025, including increasing individual and public awareness of the impact of fake or counterfeit fentanyl pills on families and young people.
Introduced April 29, 2025 by Brittany Pettersen · Last progress April 29, 2025
Declares congressional findings about the widespread production and distribution of counterfeit pills that frequently contain illicit fentanyl, highlights recent seizure and overdose statistics, and raises concern about sharply rising youth overdose rates and low youth awareness about fentanyl. The resolution frames these facts to underscore the public-health and law-enforcement threat posed by counterfeit fentanyl-laced pills and the need for heightened awareness and response.